Europe Stem Cell Market Growth, Trends and Forecasts 2017 - 2022

  • ID: 4387313
  • Report
  • Region: Europe
  • 113 pages
  • Mordor Intelligence
1 of 3
The European stem cell market is one of the most rapidly growing markets. The market is currently valued at USD 4.2 billion and is expected to grow at a CAGR of 15.7% over a forecast period.

EuropeStem Cells Market- Market Dynamics

Stem cell research is one of the most exciting areas of science in the 21st century and has the potential to revolutionize the way we treat conditions, including degenerative diseases for which few effective treatments currently exist. Researchers, governments, and the general public have high expectations from this field and they hope that this research will one day produce great results that might cure diseases such as Parkinson's, Diabetes, Cancer and Alzheimer's.

Drivers

There are several factors driving the growth of the stem cells market in Europe. Some of these are:

Increased interest in patients willing to undergo the stem cell treatment

Increase in the approval for clinical trials in stem cell research

Recent developments such as the increase in the number of clinical trials in stem cell research

Developments in the field of human stem cells

Restraints

Although there is ample scope for growth in the stem cells market in Europe, there are factors restraining it as well. Some of them are:

Expensive treatment procedures

Regulatory complications

Ethical framework

The stem cell research market is segmented on the basis of service, therapeutic application, treatment, and geography. In the stem cell segmentation by service mode, stem cell banking occupies the majority share of the market. In stem cell segmentation by treatment mode, allogeneic stem cell therapy market occupies the majority share. On the basis of geography, the market has been segmented into the UK, Spain, Germany, France and Denmark.

Key Deliverables:

Market analysis for Europestem cells market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Report Description
1.2 Research Methodology
1.3 Stakeholders
2. EXECUTIVE SUMMARY
2.1 Key Findings
2.2 Market Overview
3. MARKET OVERVIEW
3.1 Market Definition
3.1.1 Introduction
3.1.2 Basic Properties of a Stem Cell
3.1.3 Sources of Stem Cells
3.1.4 Stem Cell Products
3.1.5 Embryonic Stem Cells
3.1.6 Fetal Stem Cells
3.1.7 Adult Stem Cells
3.1.8 Amniotic Stem Cell
3.1.9 Cord Blood Stem Cell
3.1.10 Induced Pluripotent Stem Cell
3.1.11 Stem Cell Therapy
3.1.12 Complications Involved in Stem Cell Therapy
3.2 Market Drivers
3.2.1 Health Consumer Demand
3.2.2 Increase in the Patient population
3.2.3 Increase in the approval for Clinical trials in Stem Cell Research
3.2.4 Human derived Stem cells
3.2.5 Emerging Markets with excellent prospects
3.3 Market Constraints
3.3.1 Highly expensive
3.3.2 Regulatory Complications
3.3.3 Ethical and Moral Framework
3.4 Market Opportunities
3.4.1 Potential to Cure Diseases
3.4.2 Development of New Drugs
4. MARKET ANALYSIS & FORECAST
4.1 Europe Markets: Segmentation by Service
4.1.1 Stem Cell Banking
4.1.2 Stem Cell Acquisition and testing
4.1.3 Cryopreservation
4.2 Europe Markets: Segmentation by Therapeutic Applications
4.2.1 Introduction
4.2.2 Regenerative Medicine
4.2.3 Neurological Disorders
4.2.4 Orthopedic Treatments
4.2.5 Oncology disorders
4.2.6 Diabetes
4.2.7 Injuries and Wounds
4.2.8 Cardiovascular Disorders
4.3 Europe Markets: Segmentation by Treatment Types
4.4 Allogeneic Stem Cell Therapy
4.4.1 Introduction
4.4.2 Oncology
4.4.3 Cardiology
4.4.4 Bone & Cartilage
4.4.5 Neurology
4.4.6 Diabetes
4.4.7 Hematology
4.5 Autologous Stem Cell Therapy
4.5.1 Introduction
4.5.2 Oncology
4.5.3 Cardiology
4.5.4 Bone & Cartilage
4.5.5 Neurology
4.5.6 Diabetes
4.5.7 Hematology
4.6 Syngeneic Stem Cell Therapy
4.6.1 Introduction
4.6.2 Oncology
4.6.3 Cardiology
4.6.4Bone & Cartilage
4.6.5 Neurology
4.6.6 Diabetes
4.6.7 Hematology
5. European Markets: Segmentation by Geography
5.1 UK
5.2 France
5.3 Germany
5.4 Spain
5.5 Denmark
6. Regulatory Framework
6.1 UK
6.2 France
6.3 Germany
6.4 Spain
6.5 Denmark
7. COMPETITIVE LANDSCAPE
7.1 Introduction
7.2 Mergers & Acquisitions
7.3 Expansions
7.4 New Product Launch
7.5 Collaborations
8. COMPANY PROFILES
8.1 Cellerix
8.2 CellGenix
8.3 NsGene
8.4 TiGenix
8.5 VetCell Biosciences Ltd
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll